Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for HCAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -0.45M
March 31, 2026 -0.004M
December 31, 2025 -0.434M
September 30, 2025 -0.537M
June 30, 2025 -230.10M
March 31, 2025 -4.712M
December 31, 2024 37.69M
September 30, 2024 112.50M
June 30, 2024 0.698M
March 31, 2024 0.863M
December 31, 2023 0.395M
September 30, 2023 1.04M
June 30, 2023 1.202M
March 31, 2023 0.093M
December 31, 2022 0.637M
September 30, 2022 -7.539M
June 30, 2022 1.901M
Date Value
March 31, 2022 2.388M
December 31, 2021 3.916M
September 30, 2021 248.83M
June 30, 2021 4.889M
March 31, 2021 6.446M
December 31, 2020 6.74M
September 30, 2020 15.50M
June 30, 2020 150.78M
March 31, 2020 9.587M
December 31, 2019 1.098M
September 30, 2019 194.04M
June 30, 2019 -1.414M
March 31, 2019 37.66M
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018 -6.226M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. 0.055M
SCWorx Corp. 0.00
GoodRx Holdings, Inc. -6.02M
Claritev Corp. -61.64M
iSpecimen, Inc. 2.285M